9 unknown, 5 completed, 2 recruiting. 6 Phase 3, 3 Phase 1, 3 Phase 2, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Unknown 3, Completed 2, Recruiting 1 |
| Phase 1 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 3 | Unknown 3 |
| Not applicable | 1 | Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow azvudine: new trials by email Literature Review of azvudine trials Research Report on azvudine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B AZVUDINE, TAF, IFNα-2a - Chronic Hepatitis B, Azvudine | Phase 3 | Recruiting | Zhigang Ren | 120 | 2025-09-01 | 2025-12-29 |
| A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy Subjects Azvudine tablets - Renal Insufficiency | Phase 1 | Recruiting | Henan Genuine Biotech Co., Ltd. | 40 | 2025-05-20 | 2025-06-03 |
| The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19 Azvudine, Paxlovid - COVID-19, Azvudine | Completed | The First Affiliated Hospital of Zhengzhou University | 32864 | 2023-12-05 | 2024-04-05 | |
| Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect of Azvudine Treatment: a Retrospective Cohort Study Azvudine - COVID-19 | Unknown | Fifth Affiliated Hospital, Sun Yat-Sen University | 4201 | 2023-08-05 | 2023-09-21 | |
| Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness Azvudine, Placebo - COVID-19 Respiratory Infection | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 1096 | 2023-04-19 | 2024-11-25 |
| A Study to Evaluate the Pharmacokinetics and Safety of Azvudine Tablets in Healthy Adult Subjects and Healthy Elderly Subjects Azvudine tablets - Healthy | Phase 1 | Completed | Henan Genuine Biotech Co., Ltd. | 24 | 2023-04-08 | 2025-11-17 |
| A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection Azvudine, Nirmatrelvir-Ritonavir - COVID-19 | Phase 4 | Unknown | Shandong Provincial Hospital | 410 | 2023-01-21 | 2023-02-27 |
| Real-world Study Evaluating the Efficacy and Safety of Azvudine in Nursing Home Patients Azvudine - COVID-19 | Unknown | Shanghai Henlius Biotech | 400 | 2023-01-15 | 2023-01-13 | |
| Evaluate Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 in China Azvudine, Placebo - COVID-19 | Phase 2 | Unknown | Shanghai Henlius Biotech | 300 | 2023-01-06 | 2023-01-31 |
| Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 Azvudine, Placebo - SARS-CoV-2 Infection | Phase 2 / Phase 3 | Unknown | Shanghai Henlius Biotech | 1550 | 2022-12-29 | 2023-01-09 |
| An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia Azvudine - COVID-19 Respiratory Infection | Unknown | Qianfoshan Hospital | 500 | 2022-11-22 | 2023-10-03 | |
| The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial Azvudine, Paxlovid group - SARS-CoV-2 Infection | Not applicable | Unknown | Southeast University, China | 540 | 2022-10-18 | 2022-12-08 |
| A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Rilpivirine Tablets (RPV) Azvudine tablets(FNC) and Rilpivirine Tablets (RPV), Azvudine tablets (FNC) and Rilpivirine Tablets (RPV) - Healthy | Phase 1 | Completed | Henan Genuine Biotech Co., Ltd. | 15 | 2022-02-21 | 2025-06-03 |
| Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected) AZVUDINE, AZVUDINE placebo - COVID-19 | Phase 3 | Completed | HRH Pharmaceuticals Limited | 312 | 2022-01-15 | 2022-08-12 |
| Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected) AZVUDINE, AZVUDINE placebo - COVID-19 | Phase 3 | Completed | HRH Pharmaceuticals Limited | 180 | 2021-04-23 | 2022-08-12 |
| Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive Patients FNC, 3TC, TDF - HIV-infection/Aids | Phase 3 | Unknown | Henan Genuine Biotech Co., Ltd. | 720 | 2020-04-01 | 2020-03-11 |
COVID-19 (9) · Acquired Immunodeficiency Syndrome (1) · Hepatitis B, Chronic (1) · Renal Insufficiency (1)
Henan Genuine Biotech Co., Ltd. (4) · Shanghai Henlius Biotech (3) · HRH Pharmaceuticals Limited (2) · Fifth Affiliated Hospital, Sun Yat-Sen University (1) · Peking Union Medical College Hospital (1) · Qianfoshan Hospital (1) · Shandong Provincial Hospital (1) · Southeast University, China (1) · The First Affiliated Hospital of Zhengzhou University (1) · Zhigang Ren (1)
China (12) · Brazil (2) · Malaysia (1) · Philippines (1)
Gerard S. Garcia, M.D. (1) · Sheila P Figueiredo, MSc (1) · Sheila P Figueiredo, Nurse,MSc (1) · Songqiao Liu, MD. PhD. (1) · Zujiang Yu, Dr. (1)
PMID 37007788, PMID 37928473, PMID 38254211, PMID 40389963, PMID 40578868